Pharma & biotech

Leo Pharma cleaves R&D organization, hires veteran dermatologist to lead early development

An R&D reshuffle at Leo Pharma also means Thorsten Thormann, current VP for research and early development, will leave the medical dermatology company.
Photo: Leo Pharma/pr
Photo: Leo Pharma/pr
by mikkel aabenhus hemmingsen, translated by daniel pedersen

A substantial change in how Leo Pharma approaches drug development is now being followed by a new leadership structure, the Danish medical dermatology company announced in a press release on Tuesday.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
    • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Related articles

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading

    Jobs